SEC Form 4 · accession 0001179110-17-013104
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Youssef El Zein
Director · 10% Owner
Period of report
Oct 2, 2017
Accepted (ET)
Oct 4, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 2, 2017 | A | 4,721 | $2.28 | A | 534,980 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This stock was issued to the reporting person pursuant to his election under the Issuer's director compensation program in lieu of cash.
Remarks
A Power of Attorney is on record (File July 7, 2017).